[go: up one dir, main page]

CO6341608A2 - Procesos para la preparación del metil-ester del acido 4-oxo-octahidro-indol-1-carbociclico y derivados del mismo - Google Patents

Procesos para la preparación del metil-ester del acido 4-oxo-octahidro-indol-1-carbociclico y derivados del mismo

Info

Publication number
CO6341608A2
CO6341608A2 CO11030452A CO11030452A CO6341608A2 CO 6341608 A2 CO6341608 A2 CO 6341608A2 CO 11030452 A CO11030452 A CO 11030452A CO 11030452 A CO11030452 A CO 11030452A CO 6341608 A2 CO6341608 A2 CO 6341608A2
Authority
CO
Colombia
Prior art keywords
oxo
ester
acid
methyl
carbociclico
Prior art date
Application number
CO11030452A
Other languages
English (en)
Inventor
Ernst Kuesters
Murat Acemoglu
Philipp Lustenberger
Gottfried Sedelmeier
Beat Schmidt
Gerhard Penn
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41278189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6341608(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO6341608A2 publication Critical patent/CO6341608A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/14—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a un proceso para la producción de metil-éster del ácido (3aR, 4S, 7aR)-4-hidroxi-4-m-tolil-etínil-octahidro-indol-1-carboxílico (I), de enantiómeros de (2-cloro- etil)-(3-oxo-ciclohexil)-alquil-éster del ácido carbámico (II), y de enantiómeros de 1 -carbalcoxi-4-ceto-perhidro-indol (III).
CO11030452A 2008-08-12 2011-03-11 Procesos para la preparación del metil-ester del acido 4-oxo-octahidro-indol-1-carbociclico y derivados del mismo CO6341608A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8815608P 2008-08-12 2008-08-12

Publications (1)

Publication Number Publication Date
CO6341608A2 true CO6341608A2 (es) 2011-11-21

Family

ID=41278189

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11030452A CO6341608A2 (es) 2008-08-12 2011-03-11 Procesos para la preparación del metil-ester del acido 4-oxo-octahidro-indol-1-carbociclico y derivados del mismo

Country Status (22)

Country Link
US (1) US8084487B2 (es)
EP (1) EP2315748B1 (es)
JP (1) JP5468608B2 (es)
KR (1) KR101673634B1 (es)
CN (1) CN102119151A (es)
AU (1) AU2009281218B2 (es)
BR (1) BRPI0917492A8 (es)
CA (1) CA2732095C (es)
CL (1) CL2011000296A1 (es)
CO (1) CO6341608A2 (es)
EC (1) ECSP11010883A (es)
ES (1) ES2547269T3 (es)
HK (1) HK1155733A1 (es)
IL (1) IL210835A (es)
MA (1) MA32618B1 (es)
MX (1) MX2011001664A (es)
MY (1) MY151183A (es)
NZ (1) NZ590753A (es)
PE (1) PE20110415A1 (es)
RU (1) RU2513856C2 (es)
WO (1) WO2010018154A1 (es)
ZA (1) ZA201100558B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130274294A1 (en) * 2010-12-20 2013-10-17 David Carcache 4-(Hetero)Aryl-Ethynyl-Octahydro-Indole-1-Esters
US9067881B2 (en) 2011-01-24 2015-06-30 Novartis Ag 4-tolyl-ethynyl-octahydro-indole-1-ester derivatives
EP2650284A1 (en) 2012-04-10 2013-10-16 Merz Pharma GmbH & Co. KGaA Heterocyclic derivatives as metabotropic glutamate receptor modulators
CA3067688A1 (en) 2017-07-31 2019-02-07 Novartis Ag Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use
EP3661500A1 (en) 2017-07-31 2020-06-10 Novartis AG Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use
WO2020157640A1 (en) 2019-01-29 2020-08-06 Novartis Ag The use of an mglur5 antagonist for treating opioid analgesic tolerance
JP7620694B2 (ja) 2020-07-17 2025-01-23 ノバルティス アーゲー オピオイド使用の低減用医薬品及びオピオイド禁断の促進用医薬品
US20240050408A1 (en) 2020-12-11 2024-02-15 Novartis Ag Use of mglur5 antagonists for treating amphetamine addiction
EP4259127A1 (en) 2020-12-14 2023-10-18 Novartis AG Use of mglur5 antagonists for treating gambling disorder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128996D0 (en) * 2001-12-04 2002-01-23 Novartis Ag Organic compounds
GB0514296D0 (en) * 2005-07-12 2005-08-17 Novartis Ag Organic compounds
WO2008031550A2 (en) * 2006-09-11 2008-03-20 Novartis Ag Nicotinic acid derivatives as modulators of metabotropic glutanate receptors
KR101572280B1 (ko) * 2007-10-12 2015-11-26 노파르티스 아게 파킨슨병의 치료를 위한 대사성 글루타메이트 수용체 조절제
KR20110027817A (ko) * 2008-06-30 2011-03-16 노파르티스 아게 Ｍｇｌｕｒ 조절제를 포함하는 파킨슨병 치료용 조합물

Also Published As

Publication number Publication date
AU2009281218A1 (en) 2010-02-18
IL210835A (en) 2016-05-31
JP5468608B2 (ja) 2014-04-09
CA2732095C (en) 2017-04-25
ECSP11010883A (es) 2011-04-29
CN102119151A (zh) 2011-07-06
NZ590753A (en) 2012-06-29
AU2009281218B2 (en) 2013-05-16
BRPI0917492A2 (pt) 2015-08-04
PE20110415A1 (es) 2011-07-04
MY151183A (en) 2014-04-30
MA32618B1 (fr) 2011-09-01
BRPI0917492A8 (pt) 2016-07-05
RU2513856C2 (ru) 2014-04-20
JP2011530566A (ja) 2011-12-22
CA2732095A1 (en) 2010-02-18
KR101673634B1 (ko) 2016-11-07
ES2547269T3 (es) 2015-10-05
EP2315748A1 (en) 2011-05-04
WO2010018154A1 (en) 2010-02-18
RU2011108663A (ru) 2012-09-20
CL2011000296A1 (es) 2011-11-04
US20110144352A1 (en) 2011-06-16
MX2011001664A (es) 2011-03-25
US8084487B2 (en) 2011-12-27
ZA201100558B (en) 2011-10-26
EP2315748B1 (en) 2015-06-24
IL210835A0 (en) 2011-04-28
HK1155733A1 (en) 2012-05-25
KR20110042222A (ko) 2011-04-25

Similar Documents

Publication Publication Date Title
CO6341608A2 (es) Procesos para la preparación del metil-ester del acido 4-oxo-octahidro-indol-1-carbociclico y derivados del mismo
MX2012003472A (es) Produccion de derivados de acido graso.
ITMI20081164A1 (it) Processo per la produzione di esteri dell'acido levulinico da biomasse
AR062148A1 (es) Proceso quimico para la preparacion de intermediarios
CL2012000959A1 (es) Método para preparar éster aril-2-tetrazolil etílico de ácido carbámico que comprende una reducción enzimática enantioselectiva de una arilcetona para formar un compuesto de alcohol de configuración (r) y carbamatar el alcohol; método enzimático para preparar un compuesto de alcohol mediante una reducción por una oxidoreductasa.
EP2445890A4 (en) PROCESS FOR PREPARING CARBAMIC ACID (R) -1-ARYL-2-TETRAZOLYL ETHHYL ETERS
FI20106252A0 (fi) Menetelmä ja systeemi polttoainekomponenttien valmistamiseksi
ATE502001T1 (de) Herstellung von essigsäure
ECSP12011793A (es) Nuevos compuestos eficaces como inhibidores de la xantina-oxidasa, método para la preparación de los mismos y composición farmacéutica que los contiene
MY197904A (en) Method for producing substituted 5-fluoro-1h-pyrazolopyridines
EP2065736A4 (en) ANTIREFLECTION STRUCTURE, METHOD FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING AN OPTICAL ELEMENT
BR112014024493A2 (pt) método para a produção enzimática de isoprenol usando mevalonato como substrato
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
BR112013018857A2 (pt) processo para a produção dos ésteres de álcool dos ácidos graxos e composição do processo de fermentação do álcool
BRPI0817747A8 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BR112014026053A2 (pt) método de preparo de para-xileno a partir de biomassa
EP2650376A4 (en) PROCESS FOR THE PREPARATION OF L-AMINO ACID
EP4093874A4 (en) GENETICALLY MODIFIED YEAST FOR THE PRODUCTION OF CANNABIGEROLIC ACID, RETINOIC ACID AND RELATED CANNABINOIDS
EA201391481A1 (ru) Аналоги эпоксиэйкозатриеновой кислоты и способы их получения и использования
BR112013009163A2 (pt) processo para preparação de lubiprostona
EA201270343A1 (ru) Фотохимический способ получения артемисинина
BRPI0909695B8 (pt) processo de redução, processo de preparação de compostos e processo de preparação de nebivolol
ATE510818T1 (de) Kohlensäure- und schwefelsäuresalze von 3-(2,2,2- trimethylhydrazinium)propionatestern und deren verwendung zur herstellung von 3-(2,2,2- trimethylhydrazinium)propionat-dihydrat
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
EP2773611A4 (en) METHOD FOR PRODUCING OPTICALLY ACTIVE HYDROXY-AMINOCARBOXIC ACID ESTERS

Legal Events

Date Code Title Description
FG Application granted